253 related articles for article (PubMed ID: 16051888)
1. Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia.
Amano H; Hackett NR; Rafii S; Crystal RG
Circ Res; 2005 Aug; 97(4):337-45. PubMed ID: 16051888
[TBL] [Abstract][Full Text] [Related]
2. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
3. Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts.
Ichiba M; Shimomura T; Murai R; Hashiguchi K; Saeki T; Yoshida Y; Kanbe T; Tanabe N; Tsuchiya H; Miura N; Tajima F; Kurimasa A; Hamada H; Shiota G
Biochem Biophys Res Commun; 2005 Sep; 335(3):723-9. PubMed ID: 16087157
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
5. An overview of thrombopoietin: with a historical perspective.
Levin J
C R Acad Sci III; 1995 May; 318(5):609-18. PubMed ID: 7671007
[TBL] [Abstract][Full Text] [Related]
6. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
Chen Q; Solar G; Eaton DL; de Sauvage FJ
Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
[TBL] [Abstract][Full Text] [Related]
7. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
8. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
[TBL] [Abstract][Full Text] [Related]
9. [Biology of thrombopoietin and its receptors].
Robak T
Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA.
Cannizzo SJ; Frey BM; Raffi S; Moore MA; Eaton D; Suzuki M; Singh R; Mack CA; Crystal RG
Nat Biotechnol; 1997 Jun; 15(6):570-3. PubMed ID: 9181581
[TBL] [Abstract][Full Text] [Related]
11. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
Yang C; Li YC; Kuter DJ
Br J Haematol; 1999 May; 105(2):478-85. PubMed ID: 10233424
[TBL] [Abstract][Full Text] [Related]
12. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
13. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte development and platelet production.
Deutsch VR; Tomer A
Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
[TBL] [Abstract][Full Text] [Related]
16. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
[TBL] [Abstract][Full Text] [Related]
18. [Thrombopoietin and megakaryocyte differentiation].
Vainchenker W; Debili N; Norol F; Wendling F
Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
[TBL] [Abstract][Full Text] [Related]
19. [Megakaryocyte development and platelet production in normal and disease states].
Deutsch V; Katz BZ; Tomer A
Harefuah; 2010 May; 149(5):291-7, 336. PubMed ID: 20929068
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
